Harnessing E-Mindfulness Approaches for Living-After Breast Cancer – HEAL-ABC
Read more about this trial →← Back to available clinical trials
NRG-CC015
← Back to available clinical trials
← Back to available clinical trials
A022101
A Pragmatic Randomized Phase III Trial Evaluating Total Ablative Therapy for Patients with Limited Metastatic Colorectal Cancer: Evaluating Radiation, Ablation, and Surgery (ERASUR), (NCT 05673148)
Read more about this trial →← Back to available clinical trials
FC-13 (EMPIRE)
A Phase II Platform Study to Evaluate Treatment with Cemiplimab Monotherapy or Cemiplimab plus Fianlimab or Other Novel Combinations in Patients with Colorectal Cancer with Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
Read more about this trial →← Back to available clinical trials
EAQ223
Improving Diversity Participation and Enrollment in Cancer Clinical Trials
Read more about this trial →← Back to available clinical trials
NRG-GU014
Randomized Phase II Trial of Pembrolizumab and Radiation vs. Radiation and Concurrent Chemotherapy for High-Grade T1 Bladder Cancer (PARRC Trial)
Read more about this trial →← Back to available clinical trials
NRG-GU012
RANDOMIZED PHASE II STEREOTACTIC ABLATIVE RADIATION THERAPY (SABR) FOR METASTATIC UNRESECTED RENAL CELL CARCINOMA (RCC) RECEIVING IMMUNOTHERAPY (SAMURAI)
Read more about this trial →← Back to available clinical trials
A012301
A Randomized, Phase III Clinical Trial of Low‐Dose Tamoxifen for Selected Patients with Molecular Low-risk Early‐Stage Breast Cancer
Read more about this trial →← Back to available clinical trials
MK2870-012
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Read more about this trial →← Back to available clinical trials
MK2870-010
An Open-label, Randomized Phase 3 Study of MK-2870 as a Single Agent and in Combination with Pembrolizumab Versus Treatment of Physician’s Choice in Participants with HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer
Read more about this trial →← Back to available clinical trials
Tropion 05
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator’s Choice of Chemotherapy in Combination With Pembrolizumab in Patients with PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer
Read more about this trial →← Back to available clinical trials
